论文部分内容阅读
目的:评价头孢他啶对老年肺源性心脏病患者伴肺部细菌感染的临床疗效。方法:选取2015年1月—2016年10月间收治的肺源性心脏病伴肺部细菌感染患者86例临床资料,均给予头孢他啶以及吸氧、祛痰治疗,评价其治疗的总有效率和细菌清除率的差异。结果:86例患者中,治疗后的总有效率为91.86%;治疗前患者痰液经细菌培养其结果显示细菌总株数112株,治疗后有效清除104株,其细菌清除率92.86%。结论:头孢他啶用于治疗老年肺源性心脏病患者伴肺部感染,能有效清除致病菌,临床疗效比较理想,不良反应较少。
Objective: To evaluate the clinical efficacy of ceftazidime in patients with pulmonary heart disease in elderly patients with pulmonary heart disease. Methods: From January 2015 to October 2016, 86 patients with pulmonary heart disease and pulmonary bacterial infection admitted to our hospital from January 2015 to October 2016 were enrolled in this study. Both ceftazidime and ceftazidime were given as well as oxygen and expectorant treatment. The total effective rate Differences in bacterial clearance. Results: In 86 patients, the total effective rate after treatment was 91.86%. Before the treatment, the sputum of patients was cultured by bacteria and the total number of bacteria was 112. After the treatment, 104 strains were effectively removed, and the bacterial clearance rate was 92.86%. Conclusion: Ceftazidime is used to treat pulmonary heart disease in elderly patients with pulmonary heart disease, which can effectively remove pathogenic bacteria. The clinical efficacy is satisfactory and the adverse reactions are less.